The dex/CRH test - Is it better than the DST?

被引:75
作者
Watson, Stuart [1 ]
Gallagher, Peter [1 ]
Smith, Margaret S. [1 ]
Ferrier, I. Nicol [1 ]
Young, Allan H. [1 ]
机构
[1] Univ Newcastle Upon Tyne, Royal Infirm, Stanley Res Ctr, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
cortisol; corticotrophin releasing hormone; adrenal cortex hormones; dexamethasone; DST; Dex/CRH test; depression;
D O I
10.1016/j.psyneuen.2006.03.001
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The dexamethasone suppression test (DST), frequently abnormal in mood disorder patients, is considered to measure glucocorticoid receptor-mediated negative feedback. We examined the hypothesis that the, apparently more sensitive, dexamethasone/corticotrophin-releasing-hormone (dex/CRH) test unveils subtle hypothalamic-pituitary-adrenal axis disturbance not detected by the DST in 82 patients with mood disorders and 28 controls. There was a close correlation between the cortisol responses on the two tests (r(s) = 0.73, p < 0.0005). However, ROC analysis revealed that the dex/CRH test had better diagnostic performance than the DST (p=0.031). The sensitivity of delta cortisol (from the dex/CRH) was 61.9% and the specificity 71.4%. The sensitivity of 1500 h cortisol (the DST) was 66.6% and the specificity was 47.6%. This suggests that the two tests measure common pathology but that the dex/CRH test has better diagnostic utility. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:889 / 894
页数:6
相关论文
共 37 条
[1]
Altman D., 2000, STAT CONFIDENCE
[2]
STATISTICS NOTES - DIAGNOSTIC-TESTS-1 - SENSITIVITY AND SPECIFICITY .3. [J].
ALTMAN, DG ;
BLAND, JM .
BRITISH MEDICAL JOURNAL, 1994, 308 (6943) :1552-1552
[3]
ARANA GW, 1985, ARCH GEN PSYCHIAT, V42, P1193
[4]
THE DEXAMETHASONE SUPPRESSION TEST - FACT AND ARTIFACT [J].
BRADDOCK, L .
BRITISH JOURNAL OF PSYCHIATRY, 1986, 148 :363-374
[5]
Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression [J].
Bschor, T ;
Adli, M ;
Baethge, C ;
Eichmann, U ;
Ising, M ;
Uhr, M ;
Modell, S ;
Künzel, H ;
Müller-Oerlinghausen, B ;
Bauer, M .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (03) :470-478
[6]
CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1051
[7]
Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors [J].
Cassidy, F ;
Ritchie, JC ;
Verghese, K ;
Carroll, BJ .
BIOLOGICAL PSYCHIATRY, 2000, 47 (07) :677-680
[8]
A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome [J].
Castro, M ;
Elias, LLK ;
Elias, PCL ;
Moreira, AC .
CLINICAL ENDOCRINOLOGY, 2003, 59 (06) :800-805
[9]
Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies [J].
Cole, MA ;
Kim, PJ ;
Kalman, BA ;
Spencer, RL .
PSYCHONEUROENDOCRINOLOGY, 2000, 25 (02) :151-167
[10]
Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression [J].
Dinan, TG ;
O'Brien, S ;
Lavelle, E ;
Scott, LV .
PSYCHOLOGICAL MEDICINE, 2004, 34 (01) :169-172